Surgical management of primary bone tumors of the spine: validation of an approach to enhance cure and reduce local recurrence
- PMID: 20714276
- DOI: 10.1097/BRS.0b013e3181e502e5
Surgical management of primary bone tumors of the spine: validation of an approach to enhance cure and reduce local recurrence
Abstract
Study design: Multicenter ambispective cohort analysis.
Objective: The purpose of this study is to determine whether applying Enneking's principles to surgical management of primary bone tumors of the spine significant decreases local recurrence and/or mortality.
Summary of background data: Oncologic management of primary tumors of spine has historically been inconsistent, controversial, and open to individual interpretation.
Methods: A multicenter ambispective cohort analysis from 4 tertiary care spine referral centers was done. Patients were analyzed in 2 cohorts, "Enneking Appropriate" (EA), surgical margin as recommended by Enneking, and "Enneking Inappropriate" (EI), surgical margin not recommended by Enneking. Benign tumors were not included in mortality analysis.
Results: Two cohorts represented an analytic dataset with 147 patients, 86 male, average age 46 years (range: 10-83). Median follow-up was 4 (2-7) years in the EA and 6 (5.5-15.5) years in the EI. Seventy-one patients suffered at least 1 local recurrence during the study, 57 of 77 in the EI group and 14 of 70 in the EA group. EI surgical approach caused higher risk of first local recurrence (P < 0.0001). There were 48 deaths in total; 29 in the EI group and 19 in the EA. There was a strong correlation between the first local recurrence and mortality with an odds ratio of 4.69, (P < 0.0001). EI surgical approach resulted in a higher risk of mortality with a hazard ratio of 3.10, (P = 0.0485) compared to EA approach.
Conclusion: Surgery results in a significant reduction in local recurrence when primary bone tumors of the spine are resected with EA margins. Local recurrence has a high concordance with mortality in resection of these tumors. A significant decrease in mortality occurs when EA surgery is used.
Similar articles
-
Challenges of local recurrence and cure in low grade malignant tumors of the spine.Spine (Phila Pa 1976). 2009 Oct 15;34(22 Suppl):S48-57. doi: 10.1097/BRS.0b013e3181b969ac. Spine (Phila Pa 1976). 2009. PMID: 19829277
-
Efficacy evaluation of a new treatment algorithm for spinal metastases.Spine (Phila Pa 1976). 2010 Jul 1;35(15):1466-70. doi: 10.1097/BRS.0b013e3181c680b9. Spine (Phila Pa 1976). 2010. PMID: 20195197
-
Factors affecting prognosis of patients with giant cell tumors of the mobile spine: retrospective analysis of 102 patients in a single center.Ann Surg Oncol. 2013 Mar;20(3):804-10. doi: 10.1245/s10434-012-2707-6. Epub 2012 Oct 25. Ann Surg Oncol. 2013. PMID: 23096699 Clinical Trial.
-
Pediatric tumors involving the spinal column.Neurosurg Clin N Am. 2008 Jan;19(1):81-92. doi: 10.1016/j.nec.2007.09.008. Neurosurg Clin N Am. 2008. PMID: 18156051 Review.
-
Chondroma/Chondrosarcoma of the spine.Neurosurg Clin N Am. 2008 Jan;19(1):57-63. doi: 10.1016/j.nec.2007.09.007. Neurosurg Clin N Am. 2008. PMID: 18156048 Review.
Cited by
-
Construction, Validation, and Visualization of Two Web-Based Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Elderly Patients with Primary Osseous Spinal Neoplasms.J Oncol. 2022 Apr 4;2022:7987967. doi: 10.1155/2022/7987967. eCollection 2022. J Oncol. 2022. PMID: 35419057 Free PMC article.
-
Spondylectomy for Giant Cell Tumor After Denosumab Therapy.Spine (Phila Pa 1976). 2016 Feb;41(3):E178-82. doi: 10.1097/BRS.0000000000001191. Spine (Phila Pa 1976). 2016. PMID: 26579960 Free PMC article.
-
Does sagittal alignment after spinal reconstruction following en bloc tumor resection impact revision rate? A preliminary long-term retrospective study.Eur Spine J. 2025 Mar 15. doi: 10.1007/s00586-025-08789-x. Online ahead of print. Eur Spine J. 2025. PMID: 40087155
-
Oxford spinal sarcoma service: excellent oncological outcomes with a centralised multidisciplinary approach to primary spinal tumour care.Eur Spine J. 2025 May 31. doi: 10.1007/s00586-025-08893-y. Online ahead of print. Eur Spine J. 2025. PMID: 40450134
-
Remarkable regression of a giant cell tumor of the cervical spine treated conservatively with denosumab: A case report.Int J Surg Case Rep. 2016;24:22-5. doi: 10.1016/j.ijscr.2016.05.008. Epub 2016 May 10. Int J Surg Case Rep. 2016. PMID: 27179332 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials